Recent Finacing
Recent Raise
NMD Pharma is a clinical-stage biotech spun out of Aarhus University that develops a muscle electrophysiology platform and small-molecule ClC-1 modulators—lead candidate NMD670—advancing in clinical trials for neuromuscular diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
